These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1096853)

  • 1. Mutagenic activity of cyclophosphamide, ifosfamide, and trofosfamide in different genes of escherichia coli and salmonella typhimurium after biotransformation through extracts of rodent liver.
    Ellenberger J; Mohn G
    Arch Toxicol; 1975; 33(3):225-40. PubMed ID: 1096853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenic activity of major mammalian metabolites of cyclophosphamide toward several genes of Escherichia coli.
    Ellenbergen J
    J Toxicol Environ Health; 1977 Nov; 3(4):637-50. PubMed ID: 338927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic effects of cyclophosphamide, ifosfamide and trofosfamide.
    Mohn GR; Ellenberger J
    Mutat Res; 1976; 32(3-4):331-60. PubMed ID: 822325
    [No Abstract]   [Full Text] [Related]  

  • 4. Modulation of the control of mutagenic metabolites derived from cyclophosphamide and ifosfamide by stimulation of protein kinase A.
    Oesch-Bartlomowicz B; Vogel S; Arens HJ; Oesch F
    Mutat Res; 1990 Oct; 232(2):305-12. PubMed ID: 2170835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenicity studies on fenitrothion in bacteria and mammalian cells.
    Hara M; Kogiso S; Yamada F; Kawamoto M; Yoshitake A; Miyamoto J
    Mutat Res; 1989 Jan; 222(1):53-61. PubMed ID: 2643032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenicity of cancer chemotherapeutic agents in the Salmonella/microsome test.
    Benedict WF; Baker MS; Haroun L; Choi E; Ames BN
    Cancer Res; 1977 Jul; 37(7 Pt 1):2209-13. PubMed ID: 193638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A demonstration of the in vitro bacterial mutagenicity of procarbazine, using the microtitre fluctuation test and large concentrations of S9 fraction.
    Gatehouse DG; Paes DJ
    Carcinogenesis; 1983; 4(3):347-52. PubMed ID: 6339100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mutagenic activity of chlorpromazine.
    Obaseiki-Ebor EE; Akerele JO
    Mutat Res; 1988 May; 208(1):33-8. PubMed ID: 3285202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assay of 855 test chemicals in ten tester strains using a new modification of the Ames test for bacterial mutagens.
    McMahon RE; Cline JC; Thompson CZ
    Cancer Res; 1979 Mar; 39(3):682-93. PubMed ID: 371791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of mutagenicity of trioxane and dioxolane in Salmonella typhimurium.
    Kowalski Z; Spiechowicz E; Barański B
    Mutat Res; 1984 Jun; 136(3):169-71. PubMed ID: 6377055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of promutagen biotransformation in the Ames test. III. The role of conjugation with glucuronic acid and sulfate in the modification of mutagenic effect of nitrosomorpholine, diethylnitrosamine and cyclophosphamide].
    Loknitskaia NN; Rotenberg IuS; Fonshteĭn LM; Shuliakovskaia TS
    Genetika; 1986 Sep; 22(9):2259-64. PubMed ID: 3533722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of avian and rodent S-9 liver homogenates in the Ames test.
    Rosanoff KA; Jones DH; Sawyer TW
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):131-9. PubMed ID: 6328598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of mutagenicities of N-nitrosamines on Salmonella typhimurium TA100 and Escherichia coli WP2 uvrA/pKM101 using rat and hamster liver s9.
    Araki A; Muramatsu M; Matsushima T
    Gan; 1984 Jan; 75(1):8-16. PubMed ID: 6373472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activation of isophosphamide and trophosphamide to metabolites mutagenic for bacteria.
    Della Morte R; Belisario MA; Remondelli P; Mugnoz B; Staiano N
    Toxicol Lett; 1986 Jun; 31(3):183-8. PubMed ID: 3523833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity of carbon tetrachloride and chloroform in Salmonella typhimurium TA98, TA100, TA1535, and TA1537, and Escherichia coli WP2uvrA/pKM101 and WP2/pKM101, using a gas exposure method.
    Araki A; Kamigaito N; Sasaki T; Matsushima T
    Environ Mol Mutagen; 2004; 43(2):128-33. PubMed ID: 14991753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further studies on the detection of mutagenic and genotoxic activity in human faeces: aerobic and anaerobic fluctuation tests with S. typhimurium and E. coli, and the SOS Chromotest.
    Venitt S; Bosworth D
    Mutagenesis; 1986 Jan; 1(1):49-64. PubMed ID: 3325736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of ethanol and carbon tetrachloride on the mutagenic effectivity of cyclophosphamide in the host-mediated assay with Salmonella typhimurium.
    Braun R; Schöneich J
    Mutat Res; 1975 Jun; 31(3):191-4. PubMed ID: 1093018
    [No Abstract]   [Full Text] [Related]  

  • 18. Mutagenicity of glycerol chlorohydrines and of their esters with higher fatty acids present in protein hydrolysates.
    Silhánková L; Smíd F; Cerná M; Davídek J; Velísek J
    Mutat Res; 1982 Jan; 103(1):77-81. PubMed ID: 7035914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimethyl sulfoxide (DMSO) is mutagenic for bacterial mutagenicity tester strains.
    Hakura A; Mochida H; Yamatsu K
    Mutat Res; 1993 Nov; 303(3):127-33. PubMed ID: 7694129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene.
    Hayward JJ; Shane BS; Tindall KR; Cunningham ML
    Carcinogenesis; 1995 Oct; 16(10):2429-33. PubMed ID: 7586147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.